Monster Energy's Alexa Grasso Defeats Maycee Barber at UFC Fight Night in Seattle
32-Year-Old Grasso from
UFC Fight Night 271: Adesanya Vs. Pyfer was contested in front of a live crowd of 17,854 spectators inside
Saturday night's showdown between Grasso and Barber marked a rematch from their first fight in 2021, when Grasso claimed a decision victory. Stepping into the Octagon in
Grasso's opponent, 27-year-old
Energy levels were high as Grasso and Barber squared off in the Octagon. Barber started the round by pursuing her opponent aggressively, looking to land quick jabs and combinations. Meanwhile, Grasso evaded damage while finding openings for counterstrikes that dealt visible damage. Ultimately, one of those counters would decide the fight, and it came out of nowhere.
The key moments of the bout unfolded when Grasso countered an attack with a swift one-two combination, ending on a stiff left hand to the jaw that knocked Barber to the canvas. Grasso pursued with an immediate rear-naked choke, but it was already over. Referee
"Thank you for the love to everyone who's here. I'm back. Without injuries, it's a different Alexa, and I'm so happy," said Monster Energy's Grasso in her Octagon interview at UFC Fight Night Seattle. "My striking was strong in the first round, but I was training so hard to get a finish. Because I train jiu-jitsu a lot, I wanted a finish."
The violent finish, heralded by the press as a Knockout of the Year candidate, earned Grasso the UFC's
What's next for Grasso? Asked about her next fight, Grasso requested an official UFC event in her hometown: "Please bring UFC to
Monster Energy's elite UFC athletes include
For more on Monster Energy's MMA athletes, visit www.monsterenergy.com. Follow Monster Energy on YouTube, Facebook, Instagram, X, and TikTok.
For interview or photo requests, contact
About Monster Energy
Based in
CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/monster-energys-alexa-grasso-defeats-maycee-barber-at-ufc-fight-night-in-seattle-302728201.html
SOURCE Monster Energy
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Everlight Wins 2026 Madison People's Choice Award
- Ivonescimab Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC: Positive Overall Survival Results from HARMONi-2 Presented at WCLC 2026
- Phase III ARTEMIS-008 Trial Shows Risvutatug Rezetecan Significantly Improves Overall Survival in Relapsed Small-Cell Lung Cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share